Genovese Burford & Brothers Wealth & Retirement Plan Management’s Ionis Pharmaceuticals IONS Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-293	Closed	-$12K	–	215
2018 Q2	$12K	Hold	293	–	–	﹤0.01%	305
2018 Q1	$13K	Buy	+293	New	+$14.9K	﹤0.01%	295
2017 Q4	–	Sell	-293	Closed	-$14K	–	341
2017 Q3	$14K	Hold	293	–	–	0.01%	261
2017 Q2	$14K	Hold	293	–	–	0.01%	252
2017 Q1	$12K	Hold	293	–	–	﹤0.01%	278
2016 Q4	$15K	Buy	293 +126	+75%	+$4.99K	﹤0.01%	281
2016 Q3	$6K	Hold	167	–	–	﹤0.01%	333
2016 Q2	$3K	Hold	167	–	–	﹤0.01%	348
2016 Q1	$6K	Buy	+167	New	+$6.78K	﹤0.01%	299

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's IONS Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2018, closing a stake of 293 shares — an estimated $12K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in IONS in Q1 2016 and held it in 9 quarters. The position peaked at $15K in Q4 2016. 323 funds tracked by Wall St. Rank hold IONS as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Ionis Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 293 Ionis Pharmaceuticals shares in Q3 2018, an estimated $12K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 9 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Ionis Pharmaceuticals position peaked at $15K in Q4 2016.
323 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.